Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

6.01
-0.5836-8.86%
Volume:14.23M
Turnover:87.54M
Market Cap:2.42B
PE:-3.55
High:6.43
Open:6.39
Low:5.97
Close:6.59
Loading ...
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jun 27, 2024

Proposed Sale Of Securities

Form144 | Recursion Pharmaceuticals' Officer Tina Marriott proposes to sell 6000 Shares, with a total value of approximately $43290.
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Proposed Sale Of Securities

Form144|Recursion Pharmaceuticals' Director Blake Borgeson proposes to sell 11447 Shares, with a total value of approximately $1.09 Million.
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities